Search | IOVS | ARVO Journals

View

Showing 1 – 7 of 7

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2013

Lifitegrast 5.0% Ophthalmic Solution Reduces Ocular Surface Staining and Improves Symptoms in Patients with Dry Eye Disease: Results of a Phase 3 Study (OPUS-1)

Charles Semba; Gail Torkildsen; Francis D'Ambrosio; John Lonsdale; Eugene McLaurin; Richard Eiferman; Kathryn Kennedy; John Sheppard; OPUS-1 Investigators

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2669. doi:

ARVO Annual Meeting Abstract March 2012

Ophthalmic Study Subject Population Trends

Beverly A. Mersing; Dale J. Kennedy; Richard Abelson; Mark Talbert; Kathryn Kennedy; Dale Usner

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2367. doi:

ARVO Annual Meeting Abstract March 2012

Multi-Dimensional Testing to deal with Multiplicity in Clinical Trials

Swetha Surabhi; Dale Usner; Kathryn S. Kennedy; Dale J. Kennedy; Richard Abelson

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4014. doi:

ARVO Annual Meeting Abstract March 2012

Statistical Methods for Non-Detectible Data in Tear Cytokine Measurements

Heidi Goldfarb; Dale Usner; Kathryn S. Kennedy; Dale J. Kennedy; Richard Abelson

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4242. doi:

ARVO Annual Meeting Abstract March 2012

Sample Size and Power Tabulations in Dry Eye Clinical Trials

Nuttha Lurponglukana-Strand; Dale Usner; Kathryn S. Kennedy; Dale J. Kennedy; Richard Abelson

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2365. doi:

ARVO Annual Meeting Abstract March 2012

Evaluation and Selection of Statistical Analyses for Diary Data in Dry Eye Studies

Hui-Chun T. Hsu; Kathryn S. Kennedy; Dale Usner; Dale J. Kennedy; Richard Abelson

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2366. doi:

ARVO Annual Meeting Abstract April 2011

A Phase 2 Multicenter, Double-masked, Placebo-controlled Study Of A Novel Lymphocyte Function-associated Antigen-1 (LFA-1) Antagonist (SAR 1118) For Treatment Of Dry Eye

Charles P. Semba; Gail Torkildsen; John Lonsdale; Eugene McLaurin; Joel Geffin; Thomas Mundorf; Kathryn Kennedy; George Ousler

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3823. doi:

Advertisement